Department of Stomatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Front Immunol. 2022 Mar 17;13:862415. doi: 10.3389/fimmu.2022.862415. eCollection 2022.
Periodontitis is a chronic inflammatory and destructive disease caused by periodontal microbial infection and mediated by host immune response. As the main cause of loosening and loss of teeth in adults, it is considered to be one of the most common and serious oral diseases in the world. The co-existence of periodontitis and systemic chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease, diabetes and so on is very common. It has been found that interleukin-17A (IL-17A) secreted by various innate and adaptive immune cells can activate a series of inflammatory cascade reactions, which mediates the occurrence and development of periodontitis and related systemic chronic inflammatory diseases. In this work, we review the role of IL-17A in the pathomechanisms of periodontitis and related systemic chronic inflammatory diseases, and briefly discuss the therapeutic potential of cytokine targeted agents that modulate the IL-17A signaling. A deep understanding of the possible molecular mechanisms in the relationship between periodontitis and systemic diseases will help dentists and physicians update their clinical diagnosis and treatment ideas.
牙周炎是一种由牙周微生物感染引起的慢性炎症性和破坏性疾病,由宿主免疫反应介导。作为成年人牙齿松动和脱落的主要原因,它被认为是世界上最常见和最严重的口腔疾病之一。牙周炎与类风湿性关节炎、银屑病、炎症性肠病、糖尿病等系统性慢性炎症性疾病共存的情况非常普遍。现已发现,各种先天和适应性免疫细胞分泌的白细胞介素-17A(IL-17A)可以激活一系列炎症级联反应,介导牙周炎和相关系统性慢性炎症性疾病的发生和发展。在这项工作中,我们综述了 IL-17A 在牙周炎及相关系统性慢性炎症性疾病发病机制中的作用,并简要讨论了调节 IL-17A 信号的细胞因子靶向药物的治疗潜力。深入了解牙周炎与系统性疾病之间可能的分子机制将有助于牙医和内科医生更新他们的临床诊断和治疗思路。